OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Endocrinology Diabetes and Obesity is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Maximizing diabetes education efforts in vulnerable populations – newer delivery concepts	33
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?	33
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome	29
Public health concerns and increased risk of severe COVID-19 disease through androgen use	29
Updates in thyroid healthcare delivery: advancing patient-centered care	28
The female athlete triad: review of current literature	24
Advances in assessment and treatment of bone, mineral and parathyroid disorders	23
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health	23
Advances in the care of lipodystrophies	22
Nutrition and thyroid disease	22
Editorial introduction	21
Recent advances in anaplastic thyroid cancer management	20
Harm reduction strategies for androgen users: providing appropriate support and improving engagement with healthcare	20
Editorial introduction	20
Financial toxicity in thyroid cancer survivors	19
Editorial introductions	19
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis	18
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?	18
Appropriate selection of candidates for outpatient thyroidectomy	18
Interactions between antidiabetes medications and heart–brain axis	17
An update on bone in diabetes	17
Update on fracture risk assessment in osteoporosis	16
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency	16
Gastrointestinal hormones and regulation of gastric emptying	15
Preventing type 1 diabetes development and preserving beta-cell function	15

Editorial introduction	15
The use of anabolic agents in the treatment of osteoporosis: a clinical update	15
Fibrous dysplasia in children and its management	14
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia	14
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks	14
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?	13
Lipidomics in diabetes	13
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease	12
Long-acting amylin analogues for the management of obesity	12
Precision medicine in diabetes care	12
Epidemiologic changes in thyroid disease	12
Type 2 diabetes: a contemporary view from the Asian lens	11
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease	11
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders	11
Adrenal insufficiency and pregnancy	10
A short history of saturated fat: the making and unmaking of a scientific consensus	10
Growth and development in type 1 diabetes	10
An update on investigation and management of renal bone disease	10
Assisted reproductive technology outcomes and management considerations for people with epilepsy	10
Editorial introductions	10
Glucocorticoid withdrawal syndrome: what to expect and how to manage	10
The uncommon forms of congenital adrenal hyperplasia	10
Legislation, medicine, and politics: care for gender diverse youth	9
Editorial introductions	9
Effects of marijuana on reproductive health: preconception and gestational effects	9
Retrospective cohort study of changes in estimated glomerular filtration rate for patients prescribed a low carb diet	8
Novel techniques for assessment of bone tissue material properties	8
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation	8
Indications for testosterone therapy in men	7
Time to cycle regularity and health risks	7
Editorial introductions	7
An Update on Vitamin D Deficiency in the twenty-first century: nature and nurture	7
The interaction between gut microbiome and bone health	7
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment	7
Early anthropometric indicators of type 2 diabetes mellitus	7
Multifactorial chylomicronemia syndrome	7
Androgen abuse among gay and bisexual men	7
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective	6
Type 2 diabetes mellitus and cognitive function: understanding the connections	6
Polygenic risk scores for the diagnosis and management of dyslipidemia	6
Predictors of cardiovascular risk in familial hypercholesterolemia	6
When history, law, and medicine intersect	6
Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases	6
Microplastics, cardiometabolic risk, genetics and Alzheimer's disease	6
The psychosocial impact of thyroid cancer	6
Editorial introductions	6
The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?	6
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety	6
Advanced imaging and theranostics in thyroid cancer	6
Continuous glucose monitoring in primary care – are we there?	6

Testosterone and the prevention of type 2 diabetes mellitus: therapeutic implications from recent trials	6
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome	6
Radiofrequency ablation (RFA) compared to observation for benign thyroid nodules: emerging considerations for judicious use	5
Skeletal health in diabetes	5
Recent advances in the role of miRNAs in bone disease	5
Gastrointestinal regulatory peptides	5
HDL functionality in type 1 and type 2 diabetes: new insights	5
Fracture prediction tools in diabetes	5
Bridging the LatinX community care gap	5
Editorial introductions	5
Editorial: New horizons for thyroid diseases: transformative changes and tailored care	5
Aggression and criminality in androgen abusers	4
Preconception health optimization in women with polycystic ovary syndrome − how to find the time?	4
Potassium-competitive acid blockers and acid-related disorders	4
Nutritional ketosis is well-tolerated, even in type 1 diabetes: the ZeroFive100 Project; a proof-of-concept study	4
Mixed-methods research on androgen abuse – a review	4
Bone marrow adiposity in diabetes and clinical interventions	4
Overview of diabetes agents in cardiovascular disease: it takes an orchestra to play Tchaikovsky in symphony	4
Prediabetes and skeletal health	4
Utilizing point-of-care A1c to impact outcomes – can we make it happen in primary care?	4
Glutamic acid decarboxylase immunotherapy for type 1 diabetes	4
An update: maternal iodine supplementation, thyroid function tests, and child neurodevelopmental outcomes	3
Glucagon-like peptide-1 receptor agonists and safety in the preconception period	3
Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?	3
Update on management of paediatric dyslipidaemia	3
Growth and development in monogenic forms of neonatal diabetes	3
Health effects of androgen abuse: a review of the HAARLEM study	3
Use of anti-Müllerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome	3
Cardiometabolic risk and therapeutic outcomes in mild autonomous cortisol secretion	3
Editorial introductions	3
Editorial: Childhood endocrine and genetic disorders: improving adult outcomes	3
Biomarkers in gastroenteropancreatic neuroendocrine neoplasms	3
Emerging treatment for congenital adrenal hyperplasia	3
Differences in the management of thyroid nodules in children and adolescents as compared to adults	3
Cardiovascular disease in metabolic-associated fatty liver disease	3
Hypoparathyroidism update	3
Better care for women with polycystic ovary syndrome – a proposal for an international evidence based best practice framework to improve care	3
Body composition in sexual precocity	3
Current perspectives on biomarkers in metabolic bone disease	2
Use of calculated free testosterone in men: advantages and limitations	2
Under and overtreatment with thyroid hormone replacement during pregnancy	2
Editorial introduction	2
GLP-1RA based therapies in the young and old	2
Addressing genetic and environmental sources of cardiometabolic disease	2
An overview of persistent chylomicronemia: much more than meets the eye	2
Editorial introductions	2
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia	2
Selective progesterone receptor modulators and reproductive health	2
Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes	2
Enteroendocrine cell differentiation and function in the intestine	2
Editorial introductions	2
Effects of diabetes on osteocytes	2
Editorial introduction	2
Molecular tools for diagnosing diseases of the adrenal cortex	2
Eicosapentaenoic acid vs. docosahexaenoic acid for the prevention of cardiovascular disease	2
Editorial introduction	2
Mouse models of type 1 diabetes and their use in skeletal research	2
Effect of incretins on skeletal health	2
Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?	2
Obesity, insulin resistance and fertility: unresolved questions and emerging insights	2
Editorial introductions	2
Molecular testing for indeterminate thyroid nodules: past, present, and future	2
Editorial overview	2
Benefits and risks of apps for patients	2